3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
4
Lung Neoplasms
3
Ovarian Neoplasms
2
Fallopian Tube Neoplasms
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
HRD Cancer
1
Colorectal Neoplasms
1
Clinical Stage III Gastric Cancer AJCC v8
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Nivolumab
3
Cisplatin
3
atezolizumab
2
Irinotecan
2
Ipilimumab
2
Immunoglobulin G
2
Etoposide
2
Disulfides
2
Carboplatin
2
repotrectinib
1
niraparib
1
gallium Ga 68 dotatate
1
dostarlimab
1
cabozantinib
1
budigalimab
1
belinostat
1
Topotecan
1
Temozolomide
1
Specimen Handling
1
Radiosurgery
1
Radionuclide Imaging
1
Positron-Emission Tomography
1
Positron Emission Tomography Computed Tomography
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Leucovorin
1
IFL protocol
1
Fluorouracil
1
DLL3 protein, human
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Neuroendocrine
×
berzosertib
×
90 days
×
Clear all
No trials found.